Is response evaluation criteria in solid tumors ( RECIST ) effective in patient selection for radical resection after neoadjuvant immunotherapy with advanced NSCLC ?

作者
Yuan Xu,Dongjie Ma,Yingzhi Qin,Shanqing Li,Ji Li,Ying Jiang,Mengzhao Wang,Yan Xu,Jing Zhao,Minjiang Chen,Wuying Cheng,Ke Hu,Hongsheng Liu
出处
期刊:Thoracic Cancer [Wiley]
卷期号:14 (17): 1635-1639 被引量:5
标识
DOI:10.1111/1759-7714.14909
摘要

BACKGROUND: Neoadjuvant immunotherapy combined with chemotherapy has been used to treat locally advanced non-small cell lung cancer (NSCLC). Several systems have been developed for response evaluation. The aim of this study was to evaluate the predictive value of response evaluation criteria in solid tumors (RECIST) and propose modified RECIST (mRECIST). METHODS: Eligible patients received chemotherapy combined with personalized neoadjuvant immunotherapy. Radical resection was subsequently performed for potentially resectable tumors evaluated by RECIST. The resected specimens were evaluated to determine the response to neoadjuvant therapy. RESULTS: A total of 59 patients received radical resection following neoadjuvant immunotherapy combined with chemotherapy. According to RECIST, four patients had complete remission, 41 had partial remission, and 14 had progressive disease. Postoperative pathological examination showed 31 patients achieved complete pathological remission, and 13 achieved major pathological remission. The final pathological results were uncorrelated with RECIST assessment (p = 0.086). The ycN stage and pN stage were irrelevant (p < 0.001). When the cutoff of sum of diameters (SoD) is 17%, the Youden's index reached its highest value. A correlation was found between mRECIST and final pathological results. Patients with squamous cell lung cancer showed higher proportions in objective response (OR) (p < 0.001) and complete pathological remission (CPR) (p = 0.001). A shorter time to surgery (TTS) was correlated with a better OR (p = 0.014) and CPR (p = 0.010). The decrease in SoD was correlated with better OR (p = 0.008) and CPR (p = 0.002). CONCLUSIONS: mRECIST was effective for patient selection for radical resection after neoadjuvant immunotherapy with advanced NSCLC. Two modifications were suggested for RECIST: (1) the cutoff value was adjusted to 17% for partial remission. (2) Changes in lymph nodes on computed tomography were eliminated. A shorter TTS, a larger decrease in SoD and squamous cell lung cancer (vs. adenocarcinoma) were correlated with better pathological responses.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
CipherSage的应助被Evelyn采纳,获得10
1秒前
自由可兰发布了新的文献求助10
1秒前
tt发布了新的文献求助10
1秒前
亚尔驳回了田様的应助
2秒前
xudaniel发布了新的文献求助10
2秒前
荷呵呵完成签到,获得积分10
2秒前
2秒前
TT123发布了新的文献求助10
2秒前
chengzinie发布了新的文献求助10
2秒前
2秒前
张晓发布了新的文献求助10
2秒前
西柚宝宝完成签到,获得积分10
2秒前
小贾完成签到,获得积分10
3秒前
3秒前
wy.he的应助被鲤鱼采纳,获得10
4秒前
非海星关注了科研通微信公众号
4秒前
4秒前
smh发布了新的文献求助10
5秒前
CipherSage的应助被heng采纳,获得10
5秒前
5秒前
顾鹏飞发布了新的文献求助10
5秒前
阿果发布了新的文献求助10
5秒前
jiang发布了新的文献求助10
5秒前
小萝卜头完成签到,获得积分10
5秒前
jluzz完成签到,获得积分0
5秒前
小在完成签到,获得积分10
5秒前
cqnuly完成签到,获得积分10
5秒前
Hysen_L完成签到,获得积分10
6秒前
扑灯的飞蛾完成签到,获得积分10
6秒前
56455完成签到,获得积分10
6秒前
7秒前
7秒前
7秒前
福崽发布了新的文献求助10
7秒前
Ning发布了新的文献求助10
8秒前
8秒前
现代大米完成签到,获得积分10
8秒前
自由可兰完成签到,获得积分10
8秒前
轻松尔容完成签到 ,获得积分10
9秒前
Hello的应助被关关九九采纳,获得10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8160268
求助须知:如何正确求助?哪些是违规求助? 9555328
关于积分的说明 21727231
捐赠科研通 7750062
什么是DOI,文献DOI怎么找? 3427353
关于科研通互助平台的介绍 2552391
邀请新用户注册赠送积分活动 2471707